// App-Quantinova.ai

14 : APPA inhibits neutrophil pro-inflammatory functions without impairing host defence: is this a potential new therapy for arthritis?

Researchers

Presenter

  • Andrew L Cross

Principal Investigators

  • Jennifer J Hawkes

  • Helen L Wright

  • Robert J Moots

  • Steven W Edwards

Medical Centers

  • Department of Musculoskeletal Biology, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK

  • Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

  • Granulocyte-macrophage-colony stimulating factor

  • Interleukin 6

Drug/Treatment

  • GM-CSF

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved